98541-61-8

Usage

Uses

Used in Pharmaceutical Research:
(+/-)-1-benzamido-1-phenylmethaneboronic acid is used as a research compound for studying its inhibitory activity against proteasome, an enzyme complex involved in protein degradation. This activity makes it a potential candidate for the development of new drugs targeting proteasome-related diseases.
Used in Organic Synthesis:
(+/-)-1-benzamido-1-phenylmethaneboronic acid is used as a building block for the synthesis of various biologically active molecules. Its unique structure and reactivity allow for the creation of diverse compounds with potential applications in medicine and other fields.
Used in Drug Development:
The chemical properties of (+/-)-1-benzamido-1-phenylmethaneboronic acid make it a valuable tool for the development of new drugs and pharmaceuticals. Its potential as an inhibitor of proteasome and its use as a building block for synthesizing biologically active molecules contribute to its importance in drug discovery and development.

Upstream product

• 98-80-6 phenylboronic acid 
• 867182-07-8 N-[phenyl(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl]benzamide 
• 24388-23-6 2-phenyl-4,4,5,5-tetramethyl-1,3,2-dioxoborole 

Downstream Products

• 1246754-98-2 (S)-(+)-N-[phenyl(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl]benzamide 

Relevant academic research and scientific papers

Stereospecific Suzuki-Miyaura coupling of chiral α-(Acylamino) benzylboronic esters with inversion of configuration

The first invertive B-alkyl Suzuki-Miyaura coupling has been achieved. The coupling of enantioenriched α-(acylamino)benzylboronic esters with aryl bromides and chlorides took place efficiently in toluene at 80 °C in the presence of Pd(dba)2 (5 mol %), XPhos (10 mol %), K 2CO3 (3 equiv), and H2O (2 equiv). The reaction proceeded with inversion of configuration to give diarylmethanamine derivatives in high yields with high conservation of enantiomeric excesses.

Enantiomeric excess of 1,2-diols by formation of cyclic boronates: An improved method

A reliable method for determining the enantiomeric composition of 1,2-diols by the formation of diastereomeric cyclic esters with boronic acid is described. Starting from a previously reported structure of boronic chiral derivatizing agent (CDA), seven structurally related racemic CDAs were synthesized and their discriminating ability towards diols measured. The most promising amongst these was synthesized in its enantiomerically pure form according to Matteson's protocol for the stereoselective homologation of pinanediol boronates; this CDA quantitatively and rapidly reacts with 1,2-diols in very mild conditions affording a couple of diastereoisomers, whose composition can be determined via 1H NMR analysis. In particular, an attractive feature is that the resonance used for the analysis originated from the CDA as a couple of baseline-separated singlets (Δδ up to 0.3 ppm) is useful for integration.